What We Do...

TetraGene is a drug discovery and development company with a unique platform technology that is currently being used to create drugs across a broad spectrum of human disease, particularly in areas of high unmet medical need. By directly targeting genomic DNA secondary structures (G-quadruplex and i-motif DNA) TetraGene is developing small -molecule drugs aimed at validated disease-causing genes, previously considered as undruggable.

Read More

Latest News

Breaking news in the prestigious journal Nature, reveals that a major driver of the genetic disorder known as Lou Gehrigs disease (ALS) is an expansion of G-quadruplex DNA in the c9orf72 gene.

Read More